Thompson Davis & Co., Inc. Vericel Corp Transaction History
Thompson Davis & Co., Inc.
- $124 Million
- Q1 2025
Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
291Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$350 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$152 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$125 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$106 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$98.7 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.05B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...